Courtesy of Benzinga.
Top Upgrades
- Wedbush upgraded Kite Pharma Inc (NASDAQ: KITE) from Underperform to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
- Analysts at Wedbush upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Neutral to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.
- Bank of America upgraded Heico Corp (NYSE: HEI) from Neutral to Buy. HEICO shares dropped 1.30 percent to close at $83.25 on Monday.
- Analysts at Raymond James upgraded Juno Therapeutics Inc (NASDAQ: JUNO) from Market Perform to Outperform. Juno Therapeutics shares gained 0.33 percent to $36.60 in pre-market trading.
Top Downgrades
- Analysts at FBR Capital downgraded Finish Line Inc (NASDAQ: FINL) from Buy to Neutral. Finish Line shares fell 29.6 percent to $7.34 in pre-market trading.
- Canaccord Genuity downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
- Chardan Capital downgraded Intellia Therapeutics Inc (NASDAQ: NTLA) from Buy to Neutral. Intellia Therapeutics shares dropped 2.45 percent to $20.31 in pre-market trading.
- Axiom Capital downgraded JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) from Hold to Sell. JA Solar shares closed at $6.38 on Monday.
- BTIG downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Neutral. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
- Analysts at Bank of America downgraded Cemex SAB de CV (ADR) (NYSE: CX) from Buy to Neutral. Cemex shares fell 0.11 percent to close at $9.12 on Monday.
- JMP Securities downgraded Loxo Oncology Inc (NASDAQ: LOXO) from Market Outperform to Market Perform. Loxo Oncology shares rose 5.89 percent to close at $78.56 on Monday.
- SunTrust Robinson Humphrey downgraded Kite Pharma Inc (NASDAQ: KITE) from Buy to Hold. Kite Pharma shares fell 0.20 percent to $177.70 in pre-market trading.
Top Initiations
- Analysts at Macquarie initiated coverage on Carter’s, Inc. (NASDAQ: CRI) with an Outperform rating. Carter’s shares closed at $85.92 on Monday.
- Brean Capital initiated coverage on CenterState Banks Inc (NASDAQ: CSFL) with a Hold rating. CenterState Banks shares closed at $24.73 on Monday.
- Nomura initiated coverage on AveXis Inc (NASDAQ: AVXS) with a Reduce rating. The price target for AveXis is set to $52. AveXis shares closed at $96.98 on Monday.
- Analysts at Chardan Capital initiated coverage on Tivity Health Inc (NASDAQ: TVTY) with a Neutral rating. The price target for Tivity Health is set to $40. Tivity Health shares closed at $37.55 on Monday.
- KLR Group initiated coverage on Ultra Petroleum Corp. (NYSE: UPL) with a Buy rating. The price target for Ultra Petroleum is set to $14. Ultra Petroleum shares closed at $7.61 on Monday.
- Analysts at Citi initiated coverage of Venator Materials PLC (NYSE: VNTR) with a Buy rating. The price target for Venator Materials is set to $24. Venator Materials shares closed at $20.05 on Monday.
- Analysts at Aegis Capital initiated coverage on DarioHealth Corp (NASDAQ: DRIO) with a Buy rating. The price target for DarioHealth is set to $3.50. DarioHealth shares closed at $2.00 on Monday.
- Bank of America initiated coverage on Helen of Troy Limited (NASDAQ: HELE) with an Underperform rating. The price target for Helen of Troy is set to $87. Helen of Troy shares closed at $96.85 on Monday.
Latest Ratings for KITE
Date | Firm | Action | From | To |
---|---|---|---|---|
Aug 2017 | Wedbush | Upgrades | Underperform | Neutral |
Aug 2017 | Canaccord Genuity | Downgrades | Buy | Hold |
Aug 2017 | SunTrust Robinson Humphrey | Downgrades | Buy | Hold |
View More Analyst Ratings for KITE
View the Latest Analyst Ratings
Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings